Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Trial endpoint
The occurrence of a set outcome in an individual involved in a clinical trial. This can include a participant contracting a disease, a participant showing symptoms of a disease, or an abnormality in the study. The effectiveness of a treatment is usually judged on how many participants in the study reached its endpoint compared to the total amount of people involved.
See also:
Clinical trial
Clinical trial enrolment
Eligibility criteria
Drop out
Related terms
Efficacy, Peer review, Patent, Experimental drug, Epidemiology, Indication, New Drug Application (NDA), Treatment trials, Prevention trials, Interventions - clinical, Baseline, Product pipeline, Brief summary, Endpoint, Meta analysis,
Subscribe to our email news alerts
Featured jobs
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Dermavant publishes positive phase 3 data for treatment of plaque psoriasis
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- FDA issues innovative proposal to increase nonprescription drug access
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- NHS App to revolutionise digital health and care with major digital updates by 2023
- New Omicron sub-variants cause COVID-19 cases to rise in the UK
- Novartis announces positive phase 3 trial results for advanced oesophageal cancer
- Sanofi Global Health unveils new nonprofit Impact brand
- Pfizer announces commitment to achieve Net-Zero Standard by 2040
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- A creative awakening – how pharma is bringing innovation to the patient journey
- European Commission approves potential new treatment for Pompe disease
- FDA issues innovative proposal to increase nonprescription drug access
- Collaborating to define patient-centred PROs for mutual benefit
- How understanding the rare disease patient’s lived experience creates better health communications
- New medical communications agency BOLDSCIENCE launches
